Synthesis and Biological Evaluations of Cytotoxic and Antiangiogenic Triterpenoids-Jacaranone Conjugates
Hua Sun, Partick Y K Yue, Shao-Rong Wang
1State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Xian Nong Tan Street, Beijing, 100050, China. wfang@imm.ac.cn.
Background:
The development of antiangiogenic agents arises as a more effective and selective therapeutic approach for the treatment of cancer. In addition to reduced acute toxicity, the efficacy of chemotherapy could be improved when administered in combination specific antiangiogenic with cytotoxic agents. The conjugation or hybridization of bifunctional molecules is one of the alternative rational design strategies for co-administration of anticancer drugs.
Objective And Methods:
The goal of this work is to prepare the conjugates of an antiangiogenic triterpene, 3-oxo oleanolic acid, and structurally related triterpenoids with a cytotoxic semibenzoquinone, jacaranone. The cytotoxic, antiproliferative and antiangiogenic activities of segments and conjugates were determined. The possible targets of conjugates 6a-6h were predicted using Similarity Ensemble Approach (SEA).
Results:
The results showed that these conjugates are more potent in both cytotoxic and antiangiogenic assays than their corresponding parent molecules, and are also selectively more active against melanoma cells B16 and metastatic B16BL6 than the two other cancer cell lines (A549 and MCF-7) tested. The predicted antiangiogenesis related targets could involve glycogen phosphorylase, neuraminidase, interferon gamma, and tubulin beta chain.
Conclusion:
The bifunctional conjugates could be useful as dual acting antitumor/antigiogenic agents.
Insights
New bifunctional conjugates combine antiangiogenic and cytotoxic agents, showing enhanced potency against melanoma cells. These dual-action compounds offer a promising strategy for improved cancer therapy.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Cancer Research
Background:
- Antiangiogenic agents offer a selective and effective approach to cancer treatment.
- Combining antiangiogenic and cytotoxic agents can improve chemotherapy efficacy and reduce toxicity.
- Bifunctional molecule conjugation is a rational design strategy for co-administering anticancer drugs.
Purpose of the Study:
- To synthesize conjugates of an antiangiogenic triterpene (3-oxo oleanolic acid) and a cytotoxic semibenzoquinone (jacaranone).
- To evaluate the cytotoxic, antiproliferative, and antiangiogenic activities of the synthesized conjugates and their parent molecules.
- To predict potential biological targets of the conjugates using the Similarity Ensemble Approach (SEA).
Main Methods:
- Synthesis of bifunctional conjugates linking 3-oxo oleanolic acid derivatives with jacaranone.
- In vitro assays to determine cytotoxic, antiproliferative, and antiangiogenic activities.
- Computational target prediction using the Similarity Ensemble Approach (SEA).
Main Results:
- Conjugates demonstrated enhanced cytotoxic and antiangiogenic potency compared to parent molecules.
- Conjugates exhibited selective activity against melanoma cell lines (B16 and B16BL6) over other tested cancer cell lines.
- Predicted targets for antiangiogenesis included glycogen phosphorylase, neuraminidase, interferon gamma, and tubulin beta chain.
Conclusions:
- Bifunctional conjugates act as dual-acting antitumor and antiangiogenic agents.
- These novel conjugates represent a promising therapeutic strategy for cancer treatment.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
05:17Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
Related Concept Videos
Bioactivation and Tissue Toxicity
Mutagenicity and Carcinogenicity
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
